サンバイオの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2018/09/26 | 3,820 | 3,915 | 3,775 | 3,810 | +25 | +0.7% | 623,800 |
| 2018/09/25 | 3,685 | 3,865 | 3,665 | 3,785 | +105 | +2.9% | 793,700 |
| 2018/09/21 | 3,695 | 3,770 | 3,630 | 3,680 | +115 | +3.2% | 544,100 |
| 2018/09/20 | 3,615 | 3,620 | 3,510 | 3,565 | -85 | -2.3% | 575,900 |
| 2018/09/19 | 3,700 | 3,750 | 3,560 | 3,650 | -145 | -3.8% | 1,013,500 |
| 2018/09/18 | 3,810 | 3,845 | 3,690 | 3,795 | -120 | -3.1% | 462,200 |
| 2018/09/14 | 3,780 | 3,995 | 3,630 | 3,915 | +135 | +3.6% | 824,300 |
| 2018/09/13 | 3,745 | 3,780 | 3,555 | 3,780 | +105 | +2.9% | 428,700 |
| 2018/09/12 | 4,050 | 4,090 | 3,625 | 3,675 | -305 | -7.7% | 952,700 |
| 2018/09/11 | 3,925 | 4,030 | 3,835 | 3,980 | +265 | +7.1% | 975,700 |
| 2018/09/10 | 3,690 | 3,865 | 3,635 | 3,715 | +40 | +1.1% | 529,900 |
| 2018/09/07 | 3,560 | 3,705 | 3,415 | 3,675 | +65 | +1.8% | 598,600 |
| 2018/09/06 | 3,630 | 3,725 | 3,490 | 3,610 | -110 | -3% | 530,400 |
| 2018/09/05 | 3,750 | 3,880 | 3,485 | 3,720 | +25 | +0.7% | 1,161,800 |
| 2018/09/04 | 4,100 | 4,135 | 3,555 | 3,695 | -560 | -13.2% | 2,395,400 |
| 2018/09/03 | 4,300 | 4,385 | 4,145 | 4,255 | +135 | +3.3% | 876,100 |
| 2018/08/31 | 3,890 | 4,230 | 3,855 | 4,120 | +175 | +4.4% | 1,133,800 |
| 2018/08/30 | 3,915 | 3,945 | 3,815 | 3,945 | +105 | +2.7% | 464,500 |
| 2018/08/29 | 3,835 | 3,915 | 3,805 | 3,840 | +50 | +1.3% | 550,500 |
| 2018/08/28 | 3,700 | 3,895 | 3,655 | 3,790 | +170 | +4.7% | 890,500 |
| 2018/08/27 | 3,555 | 3,715 | 3,550 | 3,620 | +180 | +5.2% | 843,000 |
| 2018/08/24 | 3,365 | 3,450 | 3,345 | 3,440 | +100 | +3% | 296,300 |
| 2018/08/23 | 3,395 | 3,465 | 3,300 | 3,340 | -35 | -1% | 520,700 |
| 2018/08/22 | 3,270 | 3,440 | 3,260 | 3,375 | +140 | +4.3% | 732,600 |
| 2018/08/21 | 3,115 | 3,300 | 3,075 | 3,235 | +105 | +3.4% | 600,300 |
| 2018/08/20 | 3,095 | 3,140 | 3,025 | 3,130 | +90 | +3% | 314,500 |
| 2018/08/17 | 2,868 | 3,060 | 2,859 | 3,040 | +222 | +7.9% | 442,400 |
| 2018/08/16 | 2,885 | 2,909 | 2,784 | 2,818 | -87 | -3% | 337,400 |
| 2018/08/15 | 2,958 | 3,025 | 2,840 | 2,905 | -54 | -1.8% | 347,900 |
| 2018/08/14 | 3,000 | 3,055 | 2,951 | 2,959 | -11 | -0.4% | 205,100 |
| 2018/08/13 | 3,075 | 3,100 | 2,968 | 2,970 | -110 | -3.6% | 265,500 |
| 2018/08/10 | 3,120 | 3,160 | 3,060 | 3,080 | -40 | -1.3% | 187,400 |
| 2018/08/09 | 3,070 | 3,150 | 3,025 | 3,120 | +35 | +1.1% | 177,700 |
| 2018/08/08 | 2,995 | 3,120 | 2,995 | 3,085 | +98 | +3.3% | 223,200 |
| 2018/08/07 | 3,020 | 3,070 | 2,956 | 2,987 | -38 | -1.3% | 247,700 |
| 2018/08/06 | 3,135 | 3,150 | 3,025 | 3,025 | -115 | -3.7% | 337,800 |
| 2018/08/03 | 3,025 | 3,175 | 3,005 | 3,140 | +125 | +4.1% | 482,500 |
| 2018/08/02 | 3,000 | 3,060 | 2,971 | 3,015 | -15 | -0.5% | 193,100 |
| 2018/08/01 | 3,040 | 3,070 | 2,935 | 3,030 | +20 | +0.7% | 350,100 |
| 2018/07/31 | 2,935 | 3,055 | 2,912 | 3,010 | +63 | +2.1% | 326,500 |
| 2018/07/30 | 3,050 | 3,055 | 2,907 | 2,947 | -83 | -2.7% | 452,100 |
| 2018/07/27 | 2,882 | 3,050 | 2,881 | 3,030 | +120 | +4.1% | 497,700 |
| 2018/07/26 | 2,820 | 2,923 | 2,752 | 2,910 | +93 | +3.3% | 318,800 |
| 2018/07/25 | 2,803 | 2,870 | 2,781 | 2,817 | +12 | +0.4% | 268,400 |
| 2018/07/24 | 2,628 | 2,935 | 2,612 | 2,805 | +189 | +7.2% | 812,800 |
| 2018/07/23 | 2,646 | 2,690 | 2,598 | 2,616 | -31 | -1.2% | 213,600 |
| 2018/07/20 | 2,583 | 2,671 | 2,580 | 2,647 | +56 | +2.2% | 306,500 |
| 2018/07/19 | 2,742 | 2,784 | 2,553 | 2,591 | -136 | -5% | 597,200 |
| 2018/07/18 | 2,675 | 2,735 | 2,640 | 2,727 | +102 | +3.9% | 264,500 |
| 2018/07/17 | 2,699 | 2,752 | 2,622 | 2,625 | -88 | -3.2% | 358,600 |
1601～
1650
件表示中 / 2452件
類似銘柄と比較する
現在ご覧いただいている「サンバイオ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| サンバイオ | 228,500円 | - | - | 0.00% | - | 105.83倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
| 科研薬 | 415,900円 | +30.5% | +111.0% | 4.57% | 11.72倍 | 1.02倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| キッセイ薬 | 381,500円 | +14.5% | -2.3% | 2.36% | 13.96倍 | 0.75倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
| 鳥居薬 | 451,500円 | +7.1% | -35.0% | 2.66% | 37.33倍 | 1.04倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
| 東和薬品 | 253,500円 | +15.0% | -7.3% | 2.76% | 8.32倍 | 0.78倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
市場注目の銘柄
チャート関連のコラム
